Finally, the procaspase-1-cleaving protease significantly reduced tumor growth in the drug-resistant KPCY mouse pancreatic ductal adenocarcinoma model
Of the dozens under development, Drucker says two have especially high potential to move the needle. The first, called retatrutide, is being developed by the same manufacturer as tirzepatide and would be the first to interact with a third receptor in addition to GLP-1 and GIP
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes
Desire, arousal, blood flow, pain, hormones, and distress are different clinical targets
If dizziness persists beyond 4 weeks despite good hydration and stable dosing, it is less likely caused by semaglutide itself, and your doctor should explore other causes
Cost Breakdown: What Canadians Pay Understanding the full cost picture helps with budgeting and planning for sustained research protocols